Published: November 2016
Report Code: LS10744
Category : Medical Devices
3D bioprinting refers to the process of creating 3D structures using live cells. The process uses 3D printing technologies for crating live cells or tissue structures. These structures are used for applications in medical or healthcare. The 3D bioprinted cells or tissues are preserved into the printed construct of different materials. 3D bioprinting has revolutionized the approach towards drug discovery and development. Although, the market is still in nascent form, it is expected to witness significant growth in the coming years. Syringe based technology, pneumatic based technology, inkjet based technology, and the laser based technologies are the major technologies being used for 3D bioprinting. The 3D bioprinting products are being utilized for different applications such as tissue and organ regeneration, stem cell culture and pharmaceutical.
The global 3D bioprinting market was valued at $98.6 million in 2015, and it is expected to grow at a CAGR of 35.9% during 2016 - 2022. The increasing demand of tissues and organs for transplantation, increasing research and development activities, the innovations and advancements in technology for 3D bioprinting, and increasing compliance for 3D bioprinting in drug discovery processes are the key factors driving the growth of the global market. The different companies in the market are active in research and development activities to find enhanced solutions for the prevailing demand of regenerative medicine and the increasing need for tissue and organ transplantation. The key players in the market would target their research for the development for tissue engineering to exploit market potential.
The growing stem cell research and increasing adoption of 3D bioprinting in cosmetic industry offer ample opportunities for the growth of global market. As stem cells have potential to develop into different type of cells or tissues, a large number of research and development activities are being carried in academic institutes and research laboratories. Increasing traction for stem cell research would support the growth of the global 3D bioprinting market. The market players in cosmetic industry are collaborating with the 3D bioprinting industry players to develop tissues for cosmetic applications. A large number of collaboration of pharmaceutical or cosmetic industry players with 3D bioprinting industry players might be seen in the coming years. The key challenges faced by the major players in the global market are the high cost of bioprinting and the stringent regulatory processes. Moreover, the dearth of skilled professionals would also hamper the growth of the global market to some extent.
Among the different 3D bioprinting technologies, the syringe based 3D bioprinting generated largest revenue in the global market in 2015. The technology along with pneumatic extrusion based technology accounted for over 60% share in the global market in 2015. The pneumatic extrusion technology is expected to witness the highest growth during the forecast period. In 2015, the 3D bioprinting market for tissue and organ regeneration was largest among all the applications of 3D bioprinting.
North America accounted for the largest share in the global market in 2015 and it is expected to grow at significant rate during the forecast period. The factors driving the 3D bioprinting market in the region are increasing research and development activities and the innovations and advancements in technology. Europe was the second largest market for 3D bioprinting devices in 2015. The European market is primarily driven by increasing compliance for 3D bioprinting in pharmaceutical and cosmetic industries.
The 3D bioprinting market in Asia-Pacific would witness highest growth during the forecast period. The highest growth in the region is attributed to the increasing stem cell research, and increasing developments in China and Japan. China is expected to be the fastest growing market for 3D bioprinting globally during the forecast period.
Some of the major players operating in the global market include Organovo Holdings, Inc., CELLINK, EnvisionTEC, BioBots, Cyfuse Biomedical K.K., Aspect Biosystems Ltd., 3D Bioprinting Solutions, Ourobotics, Advanced Solutions, Inc., GeSiM, Bio3D Technologies, 3Dynamic Systems Ltd., Nano3D Biosciences, Inc., Poietis, regenHU Ltd., and Aerotech Inc.